Skip to content

CELU

Celularity Inc

NASDAQ · Healthcare · Biotechnology · US

$1.31
+3.15%
Ask drillr

Next report

Analyst consensus

Next report date
Nov 13, 2026
EPS estimate
Revenue estimate

Latest reported

Last report date
May 8, 2026
EPS actual
-$0.59
EPS estimate
Revenue actual
Revenue estimate

Track record

Trailing twelve quarters

EPS beats (12Q)
7
EPS misses (12Q)
2
EPS in line (12Q)
0
Avg surprise (4Q)
-354.2%
Revenue beats (12Q)
3
Earnings call history

No earnings call summaries available

Reported history
Report dateEPS estimateEPS actualSurpriseRevenue actual
May 8, 2026-$0.59
Nov 14, 2025-$1.50-$0.88Beat 41.33%$5.3M
Aug 29, 2025-$0.84$11.4M
May 8, 2025-$1.50-$0.59Beat 60.67%$18.1M
Dec 6, 2024-$1.40-$0.73Beat 47.86%$9.3M
Sep 27, 2024$3.40$14.7M
Jan 2, 2024-$0.04-$0.60Miss -1566.67%$3.8M
Aug 14, 2023-$0.30$3.40Beat 1233.33%$2.9M
May 22, 2023-$2.40-$2.20Beat 8.33%$3.9M
Mar 31, 2023-$0.25-$0.03Beat 88.00%$4.1M
Nov 10, 2022-$2.60$0.30Beat 111.54%$4.1M
May 16, 2022-$2.30-$4.80Miss -108.70%$5.9M

Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 13, 2026